Wound Debridement Products Market

Wound Debridement Products Market Outlook (2023 to 2033)

The wound debridement products market is anticipated to flourish at a healthy CAGR of 5.2% between 2023 and 2033. The market is expected to hold a share of US$ 7.52 billion by 2033, while the market is likely to reach a value of US$ 4.54 billion in 2023.

Factors such as product innovation, a rise in the incidence of diabetes cases, increasing healthcare spending, and a growing aging population globally are the key factors that are anticipated to drive the growth of the wound debridement products market during the forecast period. Increasing incidence of hard and heal wounds, growing aging population, rise in prevalence of chronic diseases, increasing adoption of debridement products and techniques, and rise in patient population are other factors fueling the market for wound debridement products.

In addition, the rise in demand for better healthcare, reimbursement policy, increasing healthcare expenditure, and cost-effectiveness of debridement products are driving the global market for wound debridement products. However, the economic downturn is restraining the growth of the global wound debridement products market.

Growing demographics and economies in developing countries such as the US, China, and India are expected to lead to growth in the wound debridement products market across the globe. In addition, increasing demand for wound bed preparation methods, rise in popularity of wound care at home, advancement in debridement products, and growing awareness about the benefits of timely wound management are expected to offer new opportunities for the global wound debridement products market.

Wound debridement is the medical removal of dead, damaged, infected tissue, all thickened skin or callus, nonviable, and necrotic tissue to improve the healing potential of the remaining tissue. Wound debridement products are used to treat and manage chronic ulcers, surgical wounds, traumatic wounds, and burns. Wound debridement aids in the removal of necrotic tissue bacteria and senescent cells. Sharp surgical debridement resets the proper timing of the phases of wound re-epithelialization.

Moreover, the key factor that boosts the growth of the wound debridement market includes an increase in the incidence of chronic wounds such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, arterial ulcers, and acute wounds, including burns and trauma. In addition, the rise in the aging population around the globe further drives the growth of the wound debridement market due to the increase in diabetic foot ulcers among older adults.

Wound Debridement Products Demand Analysis (2018 to 2022) vs. Market Outlook (2023 to 2033)

The global demand for wound debridement products is projected to increase at a CAGR of 5.2% during the forecast period, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 4.1%.

According to Future Market Insights, a market research and competitive intelligence provider, the wound debridement products market was valued at US$ 470.93 million in 2021. The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. In addition, increasing incidence of road accidents, burns, and trauma events across the globe is anticipated to drive the market.

Additionally, the widening base of the geriatric population and increasing initiatives by governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market. The market is primarily driven by a high incidence of diabetic foot ulcers and other target wounds, the availability of reimbursement in developed economies, and the rise in burn cases.

Moreover, the increasing adoption of debridement products and techniques to heal wounds faster propels the market growth. The micro-organisms and toxins on the wound inhibit healing and may lead to infection. Debridement removes the dead or infected tissues from the wound to promote healing.

The rising incidence of ulcers is anticipated to boost the market growth further. As per the statistics by the American Diabetes Association, in 2014, about 2.0% of the population was affected with diabetic ulcers in the United States. Similarly, about 600,000 people are affected by venous ulcers in the United States every year. Therefore, awareness programs for wound care treatment are necessary. In addition, the presence of better healthcare facilities, the adoption of advanced wound care products, the developing healthcare infrastructure, and reimbursement policies are driving the market.

Which Drivers Underin Wound Debridement Products Industry Expansion?

Increase in R&D Activities to Fuel the Market Growth

The rise in research and development activities may provide beneficial opportunities for the wound debridement products market growth in the forthcoming years.

In addition, the growing focus of manufacturers on the adoption of advanced technologies and the increase in emerging markets are the key factors expected to provide lucrative opportunities for the wound debridement products market growth over the analysis period.

Increasing Incidence of Injuries and Trauma to Accelerate the Market Growth

The rising incidence of injuries or trauma is expected to boost the growth of the wound debridement products market during the forecast period. For instance, according to the January 2018 factsheet of the World Health Organization, 20 to 30% of older people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head trauma in the United States.

Additionally, increased road accidents are expected to drive the wound debridement products market growth during the forecast period. According to the Annual Accident Report, 2018 from the European Road Safety Observatory, around 1.4 billion people suffered from injuries due to traffic road accidents in the European Union in 2016.

Increasing Prevalence Rate of Diabetes to Escalate Market Growth

The increasing prevalence rate of diabetes is another factor that is anticipated to augment the growth of the wound debridement products market in the near future. Obesity, a poor diet, and physical inactivity contribute to an increase in diabetes cases among people of all ages. Chronic wounds, particularly foot ulcers, are becoming more common in diabetics, resulting in greater use of wound debridement treatments.

Growing Incidences of Accidents to Propel the Market Growth

The wound debridement products market is expected to be driven by an increase in incidents such as car accidents, burns, and trauma events occurring around the world.

Moreover, the rising geriatric population across the globe may act as a key factor influencing the growth of the wound debridement devices market. Along with this, increasing urbanization and rising levels of disposable income are the driving factors accelerating the growth of the wound debridement devices market.

Also, increasing expenditure on healthcare infrastructure and changing lifestyles of people are the key market drivers that may further escalate the growth of the wound debridement devices market. Additionally, the rising volume of surgical procedures is fueling the industry even more.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors Are Limiting the Growth of Wound Debridement Products Market?

Lack of Standard Usage Guidelines and Trained Manpower to Limit the Market Growth

There is a higher risk for bleeding and peri-procedural pain in surgical and mechanical debridement, which limits their adoption and is likely to hinder market growth. In addition, the lack of standard usage guidelines and trained manpower is also expected to limit the market's growth.

The use of devices such as hydrological debridement devices, low-frequency ultrasound, and surgical wound debridement lack standard guidelines and usage indications for various disorders. There is also a lack of trained professionals to guide patients using these devices for different conditions in the long-term treatment plan.

High Costs Associated with the Devices

The high cost associated with enzymatic debridement and surgical devices may obstruct the growth rate of the debridement devices market. Moreover, the rising cost of treatment may challenge the market for wound debridement devices.

Additionally, a lack of awareness among people may act as a restraint and further impede the growth rate of the market during the forecast period. In addition, the high cost of enzymatic products is expected to hamper the market growth to a certain extent during the forecast period.

Country-wise Insights

North America May Continue its Dominance in the Global Wound Debridement Products Market?

Rising Incidence of Diabetes in the Region to Fuel the Market Growth

The North American wound debridement products market held a leading market share of 40.7% in 2022. Among chronic wounds, venous insufficiency ulcers constituted 50% of chronic leg ulcers, resulting in venous etiology. The annual prevalence of venous insufficiency ulcers in those aged 65 and older has been estimated to be 1.69 per 100 people per year.

The prevalence of pressure ulcers varies between 0.31% and 0.70% per year in the United States, which is in tandem with the rate of the aging population. As per statistics from the International Diabetes Federation, it is estimated that there may be over 400 million diabetics worldwide by 2025, with the greatest increases being noted in Asia, Africa, and Latin America.

In addition, around 25% of these patients are expected to develop foot ulcers during their lifetime. Increasing diabetic patients and thereby increasing incidences of diabetic foot ulcers is fueling demand in the wound debridement product market in North America. Per capita, healthcare expenditure on chronic ulcers is currently following an uptrend across both developed and developing economies, which is expected to drive the growth of the wound debridement product market in the North American region.

Another factor creating robust development in the wound debridement product market is rising government support in North America. Manufacturers of wound debridement products are getting support in the form of higher reimbursement from governments in developed countries, as the prevalence of chronic wounds like the ulcer is high in the United States. Increasing awareness among the population for advanced wound care management and improved usage of wound debridement products in home care settings is expected to boost the growth of this market.

How the Growth of the European Wound Debridement Products Market May Unfold?

High Penetration of Enzymatic Debridement Products in the Region

The wound debridement products market in Europe accumulated a market share value of 21.3% in 2022. The growth of the wound debridement products market in the European region can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence.

Growth in the European region is driven by a large patient population and increasing awareness regarding advanced healthcare products. In addition, the presence of key players and the development of advanced technology in this region are the key factors expected to escalate the wound debridement products market growth during the forecast period. Further, the growing presence of consumer market with high GDP may flourish this region's growth rate.

Where does the growth of the Asia Pacific Wound Debridement Products Market stand?

Rise in Awareness about Treatment for Wound Care in the Region

The wound debridement products market in Asia Pacific accumulated a market share of 20.3% in 2022. Asia Pacific is expected to witness significant market growth during the forecast period, attributed to various factors such as the increasing geriatric population, improving healthcare infrastructure, and the presence of a large patient base in this region. In addition, the region is expected to grow during the forecast period, owing to rising awareness about treatment for wound care and favorable reimbursement scenarios in this region.

A progressive economy, reforms to improve infrastructure, the high unmet needs of a large population, and the availability of skilled labor are expected to fuel the growth of the Asia Pacific wound debridement products market over the analysis period. For instance, introducing Goods and Services Tax (GST) in India is anticipated to reduce the tax burden and its cascading effect. This is further anticipated to improve the ease of doing business in India.

Factors such as an increase in cases of burns and trauma, as well as constantly expanding healthcare infrastructure, the presence of untapped resources, economic development, and an increase in chronic diseases, especially diabetes, are projected to boost the growth of the wound debridement products market in emerging countries in Asia Pacific.

Category Analysis

By Product Type, Which Wound Debridement Products Category May Remain Prominent?

Low-Frequency Ultrasound Devices Category of Wound Debridement Products to Beat Competition in Untiring Markets

By Product, the low-frequency ultrasound devices segment of wound debridement products is expected to rise at a revenue share of 50% in 2023. This is primarily attributed to factors such as their high efficacy in debriding and precision (lack of damage to healthy tissue) during debridement.

By End Users, which Wound Debridement Products Category to dominate?

Hospital Segment to Drive the Wound Debridement Products Market

The hospital segment is expected to dominate the market with a share of 55.6%. The increasing incidence of chronic wounds, such as diabetic foot and venous leg ulcers, is a key factor driving the hospital segment. Moreover, the incidence of chronic wounds is expected to increase with aging and may create a significant financial burden on society.

It is estimated that more than US$ 25 billion is spent by the healthcare system on treating wound-related complications every year in the United States. In addition, according to the American Diabetes Association (ADA), more than 9 to 12 billion people in America suffer from chronic ulcers. Thus, the increasing incidence of chronic diseases, especially diabetes, and the rising geriatric population across the globe are among the key factors boosting segment growth.

By Method, which Wound Debridement Products Category May Remain Prominent?

On the basis of the method, the autolytic segment of the global wound debridement products market is expected to dominate the wound debridement devices market, attributed to the surging prevalence of chronic wounds and enhancing utilization of non-invasive surgery by upcoming diagnostic centers.

The Start-up Ecosystem: How key Players are opening Frontiers for Future Growth?

Wound Debridement Products Market such as Imbed Biosciences, Kane Biotech, Axio, Grapheal, Guard Medical, Gecko, Adhesys Medical, Kerecis, Acera Surgical, and Cresilon, among others, are adopting various marketing strategies such as new product launches, geographical expansion, merger and acquisitions, partnerships and collaboration to identify the interest of potential buyers and create a larger customer base.

• Founded in 2019, Grapheal, a provider of smart solutions for monitoring wounds located in Grenoble, France, offers a wearable patch enabling continuous wound monitoring, providing caregivers with an individualized wound assessment tool. Its electronic wound patch measures and stores wound bio parameters and then communicates them to a medical cloud via a smartphone app. It allows nurses and doctors to monitor remotely the wound healing evolution.
• Guard Medical, a developer of smart wound dressing products for wound care, was established in Miami, in 2018. The company has developed an NPseal surgical product that helps in wound dressings. It uses negative pressure wound therapy that improves healing and reduces surgical site infections of closed surgical incisions.
• Established in 2013, St. Louis, a United States-based company Acera Surgical is a provider of synthetic electrospun scaffolds for regenerative medical applications. Products developed by the company include a soft, white, pliable, nonfriable, porous polymer matrix, another to be used with tensionless sutures, and a sterile, soft, non-friable, absorbable matrix that acts as a protective covering for wound defects. It is made from synthetic biocompatible materials and was designed to include a fibrous structure with high porosity. The company has received FDA clearance for both of its products.

Who are the Leading Players in the Wound Debridement Products Market?

Prominent players in the wound debridement products market are Smith & Nephew Plc., Derma Sciences, Inc., Lohmann & Rauscher International, Zimmer Biomet, DeRoyal Industries Inc., Arobella Medical LLC, Misonix, Söring GmbH, BSN Medical, and Molnlycke Healthcare AB, among others.

Recent Developments

• In January 2021, Healogics launched Healogics 2021. This Healing program is aimed at helping patients and healthcare providers with resources to improve health, heal wounds, and avoid needless amputations.
• In April 2019, RLS Global AB (Sweden) announced that ChloraSolv, its wound care product targeting diabetic foot ulcers, had successfully obtained a CE marking based on confirmation from Lloyd’s Register, acting as Notified Body, and is therefore cleared in 32 European countries for commercialization.
• In July 2023, Smith & Nephew, the global medical technology business, completed its new Research and Development and manufacturing facility for its Advanced Wound Management franchise on the outskirts of Hull, United Kingdom.

Key Players

• Smith & Nephew PLC
• Derma Sciences, Inc.
• Lohmann & Rauscher International Zimmer Biomet
• DeRoyal IndustriesInc.
• Arobella Medical LLC
• Misonix
• Söring GmbH
• BSN Medical
• Molnlycke Healthcare AB

Key Segments Covered

By Product Type:

• Hydrosurgical Debridement Devices
• Low-Frequency Ultrasound Devices
• Surgical Wound Debridement Devices
• Mechanical Debridement Pads
• Traditional Wound Debridement Devices
• Larval Therapy

By Application Type:

• Chronic Ulcers
• Surgical Wounds
• Traumatic Wounds
• Burn Cases

By End Users:

• Hospitals
• Ambulatory Surgical Centres
• Specialized Clinics
• Nursing Facilities
• Others

Key Regions Covered:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Russia
  • Rest of Europe
• Japan
• Asia Pacific Excluding Japan
  • China
  • India
  • Malaysia
  • Singapore
  • Australia
  • Rest of Asia Pacific Excluding Japan (APEJ)
• The Middle East and Africa
  • GCC Countries
  • Israel
  • South Africa
  • Middle East and Africa (MEA)